Related Experiment Video

Updated: Jan 2, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.1K

Window of opportunity clinical trial designs to study cancer metabolism

Francesca Aroldi1, Simon R Lord2

  • 1Department of Oncology, Churchill Hospital, University of Oxford, Oxford, OX3 7LE, UK.

British Journal of Cancer
|December 11, 2019
PubMed

Insights

Window of opportunity trials assess cancer drugs before treatment. These studies, particularly those on metformin, help understand cancer metabolism and inform new imaging techniques.

Area of Science:

  • Oncology
  • Pharmacology
  • Translational Medicine

Background:

  • Window of opportunity trials are crucial for early drug assessment in cancer.
  • These trials evaluate therapies in tumors unperturbed by prior treatments.
  • Metformin, an anti-mitochondrial agent, has been a focus in early window studies.

Purpose of the Study:

  • To review window study designs assessing drugs targeting cancer metabolism.
  • To highlight the role of metformin in window of opportunity trials.
  • To explore the potential of window studies in developing molecular metabolic cancer imaging.

Main Methods:

  • Review of existing literature on window of opportunity trials.
  • Analysis of studies focusing on metabolic cancer drugs, especially metformin.
  • Discussion of the application of window studies in imaging development.

Main Results:

  • Window trials provide a unique setting for pharmacodynamic assessment of cancer drugs.
  • Metformin has been extensively studied in window trials for its anti-cancer effects.
  • Window studies offer a pathway for advancing molecular metabolic cancer imaging.

Conclusions:

  • Window of opportunity trials are valuable for evaluating novel cancer therapies.
  • Further research using window studies can optimize the use of metabolic drugs like metformin.
  • Window studies are instrumental in the development of innovative cancer imaging modalities.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.5K
Assessment of the Metabolic Profile of Primary Leukemia Cells06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

10.9K

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
113
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
610
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K